Study characterizes multisystem inflammatory syndrome in adults

High dose of concentrated therapy produces several lasting benefits for children with cerebral palsy
30 September 2021
US estimates 2 million youth vapers as regulator nears key decision
30 September 2021

Study characterizes multisystem inflammatory syndrome in adults

(HealthDay)—Multisystem inflammatory syndrome in adults (MIS-A) presents about four weeks postacute COVID-19 with heterogeneous clinical symptoms, according to research published online Sept. 22 in JAMA Network Open.

Comments are closed.